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The quest for “magic bullets” has been the driving force in drug 
discovery during the last two decades. However, the increasing rate of 
drug failure over this period has occurred concurrently with the 
assumption that a drug is a selective ligand for a single target. It now 
seems likely that polypharmacology is the rule rather than the exception 
[1]. 
 
Our previous research shows that protein domains are a good proxy for 
drug targets, and that drug polypharmacology emerges as a consequence of 
the multi-domain composition of proteins [2]. In this study, we 
investigate further the idea that the domain is the druggable entity 
within a protein target. We have identified a specific class of domains 
(CATH Functional Families) as the best currently available for 
identifying drug-target interactions. We show how this opens a new 
direction in target identification with potential application in drug 
repurposing. 
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